Immunotherapy of cancer through targeting of minor histocompatibility antigens
- 30 April 2005
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 17 (2) , 202-210
- https://doi.org/10.1016/j.coi.2005.01.010
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Graft-versus-host disease after allogeneic hematopoietic stem cell transplantation induces a CD8+ T cell-mediated graft-versus-tumor effect that is independent of the recognition of alloantigenic tumor targetsBlood, 2004
- Minor Histocompatibility AntigensThe Cancer Journal, 2004
- Allogeneic reaction induces dendritic cell maturation through proinflammatory cytokine secretion1Transplantation, 2004
- Rational peptide-based tumour vaccine development and T cell monitoringSeminars in Cancer Biology, 2003
- The Role of Interferon Regulatory Factor-1 and Interferon Regulatory Factor-2 in IFN-γGrowth Inhibition of Human Breast Carcinoma Cell LinesJournal of Interferon & Cytokine Research, 2003
- Antigen‐specific immunotherapy and cancer vaccinesInternational Journal of Cancer, 2003
- Generation of minor histocompatibility antigen HA-1–specific cytotoxic T cells restricted by nonself HLA molecules: a potential strategy to treat relapsed leukemia after HLA-mismatched stem cell transplantationBlood, 2002
- An algorithm for the prediction of proteasomal cleavagesJournal of Molecular Biology, 2000
- Prevention of Graft Versus Host Disease by Inactivation of Host Antigen-Presenting CellsScience, 1999
- Genomic identification of the minor histocompatibility antigen HA‐1 locus by allele‐specific PCRTissue Antigens, 1998